Display Settings:

Format

Send to:

Choose Destination
    Arthritis Rheum. 1991 Oct;34(10):1329-31.

    Allopurinol sensitivity in a patient with chronic tophaceous gout: success of intravenous desensitization after failure of oral desensitization.

    Source

    Toronto Hospital Arthritis Centre, Ontario, Canada.

    Erratum in

    • Arthritis Rheum 1992 Jan;35(1):125.

    Abstract

    Sensitivity to allopurinol, which occurs in 10-15% of patients, can seriously limit the drug's use in chronic tophaceous gout. Oral allopurinol desensitization has been advocated for sensitive patients in whom use of the drug is warranted. We report the successful use of intravenous allopurinol desensitization in a patient with chronic tophaceous gout in whom oral desensitization had previously failed.

    PMID:
    1930322
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk